Table 2 Comparison of characteristics between BU+HIV+ patients and BU+HIV− patients (age-matched controls)
From: Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana
Characteristic | Â | |
|---|---|---|
BU+HIV+ Patients (n = 9) | BU+HIV− (n = 7) | |
Age, median years (Range) | 42 (18–50) | 40 (24–51) |
Gender, male, n (%) | 4 (44.4) | 2 (28.6) |
Gender, female, n (%) | 5 (55.6) | 5 (71.4) |
Weight, median Kg (IQR) | 50 (44, 59) | 58 (50, 65) |
Duration before seeking treatment, median weeks (IQR) | 8 (4,26) | 4 (2,10) |
Clinical Forms n (%) | ||
 Ulcer | 8(88.9) | 7 (100) |
 Nodule | 1(11.1) |  |
WHO Categories, n (%) | ||
 I (<=5 cm) | 3 (33.3) | 2 (28.6) |
 II (5-15 cm) | 5 (55.6) | 5 (71.4) |
 III (> 15 cm) | 1 (11.1) |  |
Location of the lesion, n (%) | ||
 Lower limb (LL) | 6(66.7) | 5 (71.4) |
 Upper limb (UL) | 2 (22.2) | 1 (14.3) |
 Other locations | 1 (11.1) | 1 (14.3) |
Treatment type, n (%) | ||
 SR8 | 7 (77.8) | 5 (71.4) |
 CR8 | 2 (22.2) | 2 (28.6) |
 IS2404, median cps/ml (IQR) | 500 (500, 500) | 500 (500,10,000) |
 M. ulcerans 16SrRNA, median cps/ml (IQR) | 750 (125,83,050) | 500 (0, 32,500) |
 Healing, median weeks (IQR) | 14(8,28) | 28(12,33) |